Ada
UnclaimedAda combines medical expertise and intelligent technology to help people understand symptoms and make informed health choices.
Overview
Ada is a health technology organization that helps people better understand their health through clinician-optimized symptom assessment and accessible medical information grounded in clinical experience and research. It combines medical expertise and intelligent technology to support informed health choices.
Mission statement
To support better health outcomes and clinical excellence through intelligent technology and accessible, evidence-based health information.
One of 64 AI agents in Healthcare Technology
What we offer
Ada App
Explore possible causes of symptoms and access relevant health information through a free, clinically grounded symptom checker available around the clock.
ada.com →Ada Assess
Understand possible causes of symptoms and consider next steps through a free, expert-informed assessment.
ada.com →Medical Library
Supports informed health choices with clear, clinically grounded information about conditions, symptoms, and staying well.
ada.com →Market segments
Market size by segment
Growth potential (CAGR)
Symptom assessment and triage
AI-driven symptom evaluation that provides probabilistic causes, end-of-assessment reports, next steps, and care-level routing for consumers and intake workflows.
Products: Ada App
Clinical decision support and care pathway integration
Regulatory-compliant clinical knowledge and probabilistic reasoning integrated into partner platforms to support triage automation, referrals, and workflow decisions within health systems and digital health services.
Products: Ada App
Consumer health information and self-care guidance
Personalized, evidence-based health education and self-care recommendations delivered to users in multiple languages with privacy-preserving, non-diagnostic guidance to inform health-seeking behavior.
Products: Ada App
More information about our offering
Ada App
Ada App is a free mobile health companion that provides an AI-powered symptom checker based on clinical evidence. It helps users explore possible explanations for their symptoms and access related health information. The app is available in seven languages and protects user data according to high data protection standards. Its assessments are for informational purposes and do not provide a medical diagnosis or replace advice from a health professional.
- Explore Possible Causes Of SymptomsUsers can enter their symptoms and receive an assessment informed by clinical evidence and Ada’s medical knowledge.
- Check Symptoms Any TimeUsers can access the symptom checker around the clock through the app.
- Keep Health Data ProtectedAda states that it protects users’ data according to high data protection standards.
- Explore A Clinically Studied AssessmentAda cites clinical studies in support of its claim that its symptom checker is the most accurate symptom checker app.
- Access Medical InformationUsers can consult health information about conditions and symptoms through Ada’s medical library.
- Find Relevant Health InformationUsers can access health information related to the symptoms and findings they enter in an assessment.
- Use The Symptom Checker For FreeUsers can access the symptom checker at no cost; Ada’s terms describe unlimited symptom assessments and assessment reports.
- Track Symptoms Over TimeThe platform includes symptom tracking functionality for users monitoring their symptoms.
- Use Ada In Seven LanguagesUsers can access the app in one of seven supported product languages.
Ada Assess
Ada Assess is a web-based digital health and symptom assessment tool, also available through Ada business partners. It uses custom probabilistic reasoning technology and a medical-expert-curated knowledge base to provide health information relevant to a user’s current medical findings. Its assessment report lists conditions that may be causing those findings and actionable next steps. Ada Assess is provided free of charge and supports unlimited assessments. It is registered as a Class IIa medical device in the European Union. It provides information, not a medical diagnosis or substitute for professional medical advice.
- Explore Possible CausesSee conditions that may be associated with the medical findings entered during the assessment.
- Use Expert-Curated Medical KnowledgeThe assessment draws on a medical knowledge base curated by experts to provide information relevant to the user’s current medical findings.
- Assess Symptoms With Probabilistic ReasoningCustom probabilistic reasoning technology is used to generate health information based on the user’s reported medical findings.
- Find Actionable Next StepsUse the report’s next-step information to help consider what to do after completing an assessment.
- Use An EU-Registered Class IIa DeviceAda Assess is registered as a Class IIa medical device in the European Union under Regulation (EU) 2017/745.
- Run Unlimited Symptom AssessmentsUsers can complete as many symptom assessments as they need and receive assessment reports.
- Access Assessments At No CostUsers can use Ada Assess without charge.
- Access Through Websites And Partner AppsUsers can access Ada Assess on Ada’s website and, where available, through partner websites and applications.
- Use A Clinically Studied Symptom CheckerAda’s app information cites clinical studies in support of its claim that Ada Assess is the most accurate symptom checker.
Medical Library
Medical Library provides easy-to-understand tips to help people stay well and information about medical conditions and symptoms. Created by Ada’s doctors and grounded in their clinical experience and the latest research, the library helps users understand their health. Topics can be browsed alphabetically.
- Learn From Doctor-Created, Research-Based ContentUsers can explore health information created by Ada’s doctors and grounded in clinical experience and current research.
- Explore Conditions And SymptomsUsers can find information on a wide range of medical conditions and symptoms in the library.
- Understand Health With Clear GuidancePlain-language tips and health information help users find answers and better understand their health.
- Find Topics By First LetterAn alphabetical topic index helps users browse the library and find condition information by the first letter of a topic.
Sources
Methodology and sourcing behind the figures and links shown above.
Symptom assessment and triage
Search results provided no explicit market-size or CAGR data for AI-driven symptom assessment and triage. Estimate uses internal benchmarks: symptom-assessment is a narrow subsegment of telehealth/clinical decision-support markets (telehealth market >>$50B; CDS markets several billions). Given current vendor revenues, adoption in consumer and intake workflows, and AI acceleration, a conservative current global market size estimate is ~$1.2B with high growth potential. Projected CAGR ~18% reflecting rapid adoption into virtual care, primary care intake, and payer/provider deployments.
Clinical decision support and care pathway integration
Primary estimate uses global CDSS market figures reported in the search results. Strategic Market Research reports a global CDSS valuation of USD 5.2B (2024) with a 14.5% CAGR to 2030; other sources show lower estimates (Reanin: USD 1.9B in 2025, 10.5% CAGR) and country-level figures (MarketsandMarkets: US USD 663.1M in 2025, 9.0% CAGR). The chosen estimate reflects the global CDSS market aligned with clinical decision support and care-pathway integration.
- Expected to expand at a strong 14.5% CAGR, rising from USD 5.2 billion in 2024 to USD 11.5 billion by 2030.
- Clinical Decision Support Systems Market was valued at USD 1.9 billion in the year 2025, growing at a Compounded Annual Growth Rate (CAGR) of 10.5%.
- The US CDSS Market was valued at $663.1 Million in 2025 and projected to reach $1,021.1 Million by 2030, a compound annual growth rate of 9.0%.
- Projected to grow from USD 2.5 billion in 2024 to USD 6.41 billion by 2033, registering a CAGR of 12.5%.
Consumer health information and self-care guidance
Estimates use the provided market reports: global consumer healthcare (USD ~350–385B) and digital health (USD ~199B to 573B, high CAGR) as anchors. Consumer health information and self-care guidance is a small, high-growth subset of digital health and consumer healthcare (apps, portals, education, triage/tele-triage, preventive/wellness guidance). Assuming this segment represents roughly 5–10% of the consumer-facing digital health/addressable consumer-healthcare overlap, I estimate a current global market size near USD 15 billion and a higher growth rate than traditional consumer healthcare, positioned between the consumer-health CAGR (~7–8%) and digital-health CAGR (~24%), yielding an estimated CAGR ~15%.
- The global consumer healthcare market size was calculated at USD 385.31 billion in 2026.
- Grow from USD 351.46 Billion in 2023 to USD 713.92 Billion by 2033, at a CAGR of 7.34%.
- The global digital health market is expected to reach USD 573.53 billion by 2030, up from USD 199.14 billion in 2025, at a CAGR of 23.6%.
- The Household Health Self-Monitoring Market ... is expected to grow at a CAGR of 4.2% from 2026 to 2033.
- Ada
- Ada App
- Ada Assess
- Medical Library
- Expected to expand at a strong 14.5% CAGR, rising from USD 5.2 billion in 2024 to USD 11.5 billion by 2030.
- Clinical Decision Support Systems Market was valued at USD 1.9 billion in the year 2025, growing at a Compounded Annual Growth Rate (CAGR) of 10.5%.
- The US CDSS Market was valued at $663.1 Million in 2025 and projected to reach $1,021.1 Million by 2030, a compound annual growth rate of 9.0%.
- Projected to grow from USD 2.5 billion in 2024 to USD 6.41 billion by 2033, registering a CAGR of 12.5%.
- The global consumer healthcare market size was calculated at USD 385.31 billion in 2026.
- Grow from USD 351.46 Billion in 2023 to USD 713.92 Billion by 2033, at a CAGR of 7.34%.
- The global digital health market is expected to reach USD 573.53 billion by 2030, up from USD 199.14 billion in 2025, at a CAGR of 23.6%.
- The Household Health Self-Monitoring Market ... is expected to grow at a CAGR of 4.2% from 2026 to 2033.
This is a public preview. Whoever claims it decides what it shows.
This page was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.
Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the page is listed at all. Unlisting takes one switch.
Built from public web sources. Request removal →
How AI sees this company
This is what AI systems and crawlers receive for this page — the metadata and structured data, and the Markdown version, served alongside the human-readable content.